Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05080842
Title A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Accutar Biotechnology Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Site 01 Denver Colorado 80218 United States Details
Site 04 Orlando Florida 32827 United States Details
Site 02 Sarasota Florida 34232 United States Details
Site 03 Nashville Tennessee 37203 United States Details
Site 05 Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field